CRWV insider notice: 250K common shares to be sold on NASDAQ

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) filed a Form 144 reporting a proposed sale of 250,000 common shares through Morgan Stanley Smith Barney LLC on the NASDAQ with an approximate sale date of 08/19/2025. The filing lists an aggregate market value of $24,200,000 and shows 370,470,348 shares outstanding.

The shares were acquired as founders shares on 11/13/2017 from the issuer; no payment financing terms are reported. The filer certifies they are unaware of any undisclosed material adverse information and notes no securities sold in the past three months. No individual filer name or additional transaction details are provided in the notice.

Positive

• Transparent disclosure of a proposed insider sale through Form 144 with broker and trade details
• Acquisition provenance provided (founders shares acquired 11/13/2017), which clarifies holding period

Negative

• High aggregate value ($24.2M) could be perceived negatively by some investors if executed, though size relative to outstanding shares is small
• Filer identity and trading-plan dates omitted, limiting context for motivations and schedule

Insights

Securities Analyst

TL;DR: Routine insider notice of sale for 250,000 shares valued at $24.2M; market impact appears limited absent other disclosures.

The Form 144 documents a proposed sale rather than a completed trade and identifies Morgan Stanley Smith Barney as the broker. The position size (250,000 shares) equals about 0.068% of the reported 370,470,348 shares outstanding, suggesting the transaction is small relative to total float. The filing supplies acquisition provenance (founders shares dated 11/13/2017), which clarifies this is not a recent purchase-based sale. Because no insider name, sale pacing, or plan details are included, the notice is informational; its market impact depends on whether the sale executes and on overall trading volume at execution.

Corporate Governance Expert

TL;DR: Disclosure follows Rule 144 mechanics and includes the standard representation about material nonpublic information.

The filer affirms there is no undisclosed material adverse information and references Rule 10b5-1 planning language without providing plan dates, indicating compliance-focused disclosure. The securities were acquired as founders shares in 2017, which is relevant for holding-period qualification. The absence of the filer’s name or a stated trading plan limits assessment of governance context; however, filing the Form 144 itself demonstrates adherence to required reporting when selling restricted or control securities.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	250000	24200000.00	370470348	08/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			250000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did CoreWeave (CRWV) disclose in the Form 144?

The filing reports a proposed sale of 250,000 common shares via Morgan Stanley Smith Barney on the NASDAQ with an approximate sale date of 08/19/2025 and an aggregate market value of $24,200,000.

When were the shares being sold originally acquired?

The shares were acquired as founders shares on 11/13/2017 from the issuer.

How many CoreWeave shares are outstanding according to the filing?

The Form 144 lists 370,470,348 shares outstanding.

Does the filing indicate any undisclosed material information?

The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.

Were there any other securities sold by the filer in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.